Browsing by Author Charles (nee Slaviero), Kellie

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)Citation
2003Baseline Nutritional Assessment in Advanced Cancer Patients Receiving Palliative ChemotherapyCharles (nee Slaviero), Kellie; Clarke, Stephen; Read, Jane; Rivory, Laurent; School of Medical Sciences: Pharmacology; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: MedicineBaseline Nutritional Assessment in Advanced Cancer Patients Receiving Palliative Chemotherapy, Nutrition and Cancer: an international journal, vol.46,(2),2003,pp 148-157
2011Clinical, laboratory and molecular factors predicting chemotherapy efficacy and toxicity in colorectal cancerCharles (nee Slaviero), Kellie; Chua, Wei; Clarke, Stephen; Kho, Patricia; Moore, Melissa; School of Medical Sciences: Pharmacology; Concord Clinical School: Medicine; Northern Clinical School: Kolling Institute; Concord Clinical School: Medicine; Concord Clinical School: MedicineClinical, laboratory and molecular factors predicting chemotherapy efficacy and toxicity in colorectal cancer, Critical Reviews in Oncology / Hematology, vol.79, 3, 2011,pp 224-250
2013CYP3A4 intron 6 C>T SNP (CYP3A4*22) encodes lower CYP3A4 activity in cancer patients, as measured with probes midazolam and erythromycinCharles (nee Slaviero), Kellie; Clarke, Stephen; De Graan, Anne Joy; Elens, Laure; Haufroid, Vincent; Mathijssen, Ron Hj; Nieuweboer, Annemieke; Van Schaik, Ron Hn; School of Medical Sciences: Pharmacology; Concord Clinical School: MedicineCYP3A4 intron 6 C>T SNP (CYP3A4*22) encodes lower CYP3A4 activity in cancer patients, as measured with probes midazolam and erythromycin, Pharmacogenomics, vol.14, 2, 2013,pp 137-149
2002Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase responseCharles (nee Slaviero), Kellie; Clarke, Stephen; Rivory, Laurent; School of Medical Sciences: Pharmacology; Concord Clinical School: ANZAC Research Institute; Central Clinical School: MedicineHepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase response, British Journal of Cancer, vol.87, 3,pp 277-280
2010Inflammation and Cancer: Causes and ConsequencesCharles (nee Slaviero), Kellie; Chua, Wei; Clarke, Stephen; Moore, M; School of Medical Sciences: Pharmacology; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; MedicineInflammation and Cancer: Causes and Consequences, Clinical Pharmacology and Therapeutics, vol.87, 4,pp 504-508
2003Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapyCharles (nee Slaviero), Kellie; Clarke, Stephen; Rivory, Laurent; School of Medical Sciences: Pharmacology; Concord Clinical School: ANZAC Research Institute; Central Clinical School: MedicineInflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy, Lancet Oncology, vol.4,(4),2003,pp 224-232
2011Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancerCharles (nee Slaviero), Kellie; Chua, Wei; Clarke, Stephen; Baracos, V E; School of Medical Sciences: Pharmacology; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteNeutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer, British Journal of Cancer, vol.104, 8, 2011,pp 1288-1295
2009Predictive biomarkers of clinical response to targeted antibodies in colorectal cancer.Charles (nee Slaviero), Kellie; Chua, Wei; Clarke, Stephen; Moore, Melissa; School of Medical Sciences: Pharmacology; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstitutePredictive biomarkers of clinical response to targeted antibodies in colorectal cancer., Current Opinion in Molecular Therapeutics, vol.11, 6,pp 611-622
2012Systemic inflammation and prediction of chemotherapy outcomes in patients receiving docetaxel for advanced cancerCharles (nee Slaviero), Kellie; Chua, Wei; Clarke, Stephen; School of Medical Sciences: Pharmacology; Concord Clinical School: Medicine; Concord Clinical School: MedicineSystemic inflammation and prediction of chemotherapy outcomes in patients receiving docetaxel for advanced cancer, Supportive Care in Cancer, vol.20, 8, 2012,pp 1869-1874
2006Transcriptional repression of hepatic cytochrome P450 3A4 gene in the presence of cancer.Brown, Sandra; Charles (nee Slaviero), Kellie; Clarke, Stephen; Liddle, Christopher; Rivory, Laurent; Robertson, Graham; International Office; School of Medical Sciences: Pharmacology; Concord Clinical School: ANZAC Research Institute; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteTranscriptional repression of hepatic cytochrome P450 3A4 gene in the presence of cancer., Clinical Cancer Research, vol.12,(24),2006,pp 7492-7497
2011Use of inflammatory markers to guide cancer treatmentCharles (nee Slaviero), Kellie; Chua, Wei; Clarke, Stephen; Kao, S. C. H.; McMillan, D; Moore, M; Phan, V. H.; Tan, C; School of Medical Sciences: Pharmacology; Concord Clinical School: Medicine; Northern Clinical School: Kolling InstituteUse of inflammatory markers to guide cancer treatment, Clinical Pharmacology and Therapeutics, vol.90, 3, 2011,pp 475-478